1 IPO Expected This Week
From IPO Analysis from Seeking Alpha
December 18, 2012 - 6:43am
By Renaissance Capital IPO Research:
The following IPO is expected to price this week:
Audeo Oncology (AURX), which is developing a combination therapy in Phase 3 trial for metastatic colorectal cancer, plans to raise $49 million by offering 3.3 millionComplete Story »
Continue reading this article »Share This Article: